Business Context and Reporting Period
This Form 6-K filing by Wearable Devices Ltd. covers the month of August 2026, with the report dated August 10, 2026. The filing primarily addresses the resolution of a shareholder dispute, the completion of a private placement, and a restructuring of the Board of Directors.
Key Financial Metrics
- Private Placement Proceeds: The Company received aggregate gross proceeds of approximately $3.3 million from a private placement with a single institutional investor, completed on August 10, 2026. This amount is before deducting placement agent fees and offering expenses.
- Financing Commitment: J.B.D Innovation Ltd. (JBD) has committed to provide up to $12.0 million in debt financing (convertible to ordinary shares) over the next 24 months, contingent upon the Board determining the Company lacks sufficient resources to fund operations.
- Revenue, Profit, and Cash Flow: The filing text does not provide specific values for revenue, net income, operating cash flow, or margins for the period.
- Debt and Liquidity: No specific debt balances or liquidity ratios are disclosed in this text, other than the conditional financing commitment.
Material Changes and Corporate Governance
The filing details significant changes resulting from a Cooperation Agreement entered into on August 7, 2026, to resolve a shareholder dispute and court proceedings that had temporarily halted the private placement.
- Board Restructuring: Two directors, Ms. Lurie and Mr. Wagner, will resign. Four new independent directors will be appointed: Mr. Avichay Vardi, Mr. Oz Adler, Mr. Gabriel Kabazo, and Ms. Hila Kiron Revach. The Board will consist of seven members following these changes.
- Legal Resolution: The Court Proceedings in the Haifa District Court were dismissed on August 10, 2026, with no order as to costs. Shareholders agreed to withdraw their demand for a special general meeting.
- Shareholder Conduct: Shareholders agreed to a two-year standstill provision, refraining from actions to hinder or influence corporate governance, operations, or management, except as permitted by the agreement.
Outlook, Risks, and Contingencies
Management commentary is limited to the execution of the Cooperation Agreement and the Side Letter. The filing includes standard forward-looking statements regarding the implementation of the board changes and the potential funding of the Financing Commitment.
- Contingent Financing: The $12.0 million financing commitment is not guaranteed; it is conditional on the Board's good faith determination that the Company lacks sufficient resources for the next 24 months. Terms such as interest rates and conversion mechanics are yet to be negotiated.
- Risks: The filing references risks described in the Company's Form 20-F for the year ended December 31, 2025. Actual results may differ materially from forward-looking statements due to inherent uncertainties.
- Unusual Items: The temporary injunction halting the private placement on August 2, 2026, and the subsequent settlement represent unusual corporate governance events.
Investor Verification Checklist
- Verify the net proceeds of the $3.3 million private placement after deducting placement agent fees and offering expenses.
- Confirm the exact effective date for the resignation of departing directors and the appointment of new directors (three business days following the dismissal of court proceedings).
- Review the full text of the Side Letter (Exhibit 10.2) to understand the specific triggers and terms for the $12.0 million contingent financing commitment.
- Assess the Company's current cash runway to determine the likelihood of triggering the financing commitment from JBD.
- Examine the biographies of the new directors to evaluate their independence and relevant industry experience.